Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Cascadian Therapeutics Inc (CASC)

4.27 0.1 (2.4%)

01-19 16:00

Open:

4.17

Pre. Close:

4.17

High:

4.385

Low:

4.17

Volume:

308,881

Market Cap:

216M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

4.38 - 4.41

4.41 - 4.42

Low:

4.12 - 4.14

4.14 - 4.16

Close:

4.23 - 4.27

4.27 - 4.3

Technical analysis  (as of: 2018-01-19 4:23:50 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 5.12     One year: 5.98

Support:

Support1: 3.85    Support2: 3.52

Resistance:

Resistance1: 4.38    Resistance2: 5.12

Pivot:

3.89

Moving Averages:

MA(5): 4.16     MA(20): 3.84

MA(100): 3.99     MA(250): 3.99

MACD:

MACD(12,26): 0.07     Signal(12,26,9):

%K %D:

%K(14,3): 92.08     %D(3): 90.42

RSI:

RSI(14): 64.66

52-Week:

High: 4.97  Low: 3.18  Change(%): 17.0

Average Vol(K):

3-Month: 34218  10-Days 32395

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
CASC has closed below upper band by 6.0%. Bollinger Bands are 58.1% wider than normal. The large width of the bands suggest high volatility as compared to CASC's normal range. The bands have been in this wide range for 1 bars. This is a sign that the current trend might continue.

Headline News

Tue, 21 Nov 2017 15:11:15 GMT
Cascadian Therapeutics: Upside In Other Her2+ Indications

Tue, 02 Jan 2018 13:30:00 GMT
Cascadian Therapeutics Receives Pediatric Investigation Plan Waiver from the ...

Thu, 09 Nov 2017 00:45:00 GMT
Cascadian Therapeutics' (CASC) CEO Scott Myers on Q3 2017 Results - Earnings ...

Wed, 09 Aug 2017 02:15:00 GMT
Cascadian Therapeutics' (CASC) CEO Scott Myers On Q2 2017 Results - Earnings ...

Mon, 13 Mar 2017 19:52:30 GMT
Cascadian Therapeutics Announces Changes to Board of Directors

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

50.56

Shares Float (M)

26.42

% Held by Insiders

0.42

% Held by Institutions

81.64

Shares Short (K)

1870

Shares Short Prior Month (K)

1680

Stock Financials

EPS

-1.260

EPS Est. Current Year

5.020

EPS Est. Next Year

-1.090

EPS Est. Next Quarter

Forward EPS

1.#IO

Book Value (p.s.)

2.460

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-28.6

Return on Equity (ttm)

-48.5

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-1.005

Qtrly Earnings Growth

Operating Cash Flow (M)

-45.94

Levered Free Cash Flow (M)

-28.33

atoplab.com

Valuation

P/E

-3.39

P/E Growth Ratio

0.02

P/BV

1.74

P/S

P/CF

-4.70

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

1995-05-08

Forward Dividend

Last Split Date

2016-11-29

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.